Because most of the lung cancer patients are males and DAB2IP deficient was also founded in lung cancer [15], it is likely that the genetic variation in DAB2IP gene may contribute to increase the risk of lung cancer as it did in prostate cancer. The gene discussed is DAB2IP; the disease is Familial prostate cancer.